ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 54 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $5,278,000 | -32.3% | 5,190,000 | -27.8% | 0.02% | -32.4% |
| Q4 2020 | $7,796,000 | +5.6% | 7,190,000 | 0.0% | 0.03% | +17.2% |
| Q3 2020 | $7,385,000 | -6.9% | 7,190,000 | 0.0% | 0.03% | -27.5% |
| Q2 2020 | $7,936,000 | +2.0% | 7,190,000 | -6.5% | 0.04% | -20.0% |
| Q1 2020 | $7,777,000 | -31.9% | 7,690,000 | -22.6% | 0.05% | +31.6% |
| Q4 2019 | $11,416,000 | +0.0% | 9,940,000 | -0.6% | 0.04% | -9.5% |
| Q3 2019 | $11,413,000 | -3.6% | 10,000,000 | 0.0% | 0.04% | -2.3% |
| Q2 2019 | $11,845,000 | +34.6% | 10,000,000 | +53.8% | 0.04% | +30.3% |
| Q1 2019 | $8,802,000 | +41.4% | 6,500,000 | +12.1% | 0.03% | +17.9% |
| Q4 2018 | $6,227,000 | -33.1% | 5,800,000 | -34.1% | 0.03% | -17.6% |
| Q3 2018 | $9,308,000 | +7.7% | 8,800,000 | 0.0% | 0.03% | -5.6% |
| Q2 2018 | $8,643,000 | +28.4% | 8,800,000 | +29.4% | 0.04% | +16.1% |
| Q1 2018 | $6,730,000 | – | 6,800,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Man Investments (CH) AG | 7,000,000 | $6,536,000 | 3.36% |
| Sonora Investment Management, LLC | 15,550,000 | $14,486,691,000 | 3.04% |
| Jabre Capital Partners S.A. | 7,550,000 | $7,050,000 | 0.96% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 70,972,000 | $66,281,000 | 0.96% |
| MACKAY SHIELDS LLC | 10,243,000 | $9,558,000 | 0.43% |
| ARISTEIA CAPITAL, L.L.C. | 7,500,000 | $6,998,000 | 0.38% |
| OAKTREE CAPITAL MANAGEMENT LP | 27,100,000 | $25,384,000 | 0.33% |
| SSI INVESTMENT MANAGEMENT LLC | 2,671,000 | $2,485,000 | 0.22% |
| Verition Fund Management LLC | 2,000,000 | $1,866,000 | 0.20% |
| PALISADE CAPITAL MANAGEMENT, LP | 5,849,000 | $5,453,000 | 0.19% |